SPY335.84-2.98 -0.88%
DIA279.57-1.46 -0.52%
IXIC10,910.28-140.19 -1.27%

Amicus Therapeutics Q1 EPS $(0.350) Misses $(0.280) Estimate, Sales $60.500M Beat $57.490M Estimate

Amicus Therapeutics (NASDAQ:FOLD) reported quarterly losses of $(0.350) per share which missed the analyst consensus estimate of $(0.280) by 25 percent. This is a 10.26 percent increase over losses of $(0.390) per share

Benzinga · 05/07/2020 11:30

Amicus Therapeutics (NASDAQ:FOLD) reported quarterly losses of $(0.350) per share which missed the analyst consensus estimate of $(0.280) by 25 percent. This is a 10.26 percent increase over losses of $(0.390) per share from the same period last year. The company reported quarterly sales of $60.500 million which beat the analyst consensus estimate of $57.490 million by 5.24 percent. This is a 77.70 percent increase over sales of $34.046 million the same period last year.